Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate as a fixed-dose combination in Japanese and Caucasian healthy subjects

被引：0
|
作者：
Tillmann, Hanns-Christian [1 ]
Inoue, Satoru [2 ]
Vaidya, Soniya [3 ]
Sakita, Yohei [2 ]
Machineni, Surendra [4 ]
Kobayashi, Kiyoshi [2 ]
Furihata, Kenichi [5 ]
机构：
[1] Novartis Inst BioMed Res, Basel, Switzerland
[2] Novartis Pharma KK, Tokyo, Japan
[3] Novartis Inst BioMed Res, Cambridge, England
[4] Novartis Healthcare Pvt Ltd, Hyderabad, Telangana, India
[5] Keikokai Med Corp, P One Clin, Tokyo, Japan
来源：
EUROPEAN RESPIRATORY JOURNAL | 2019年 / 54卷
关键词：
Asthma; -; management;
D O I：
10.1183/13993003.congress-2019.PA2541
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA2541
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate administered as an inhaled fixed-dose combination in Japanese and Caucasian healthy subjects
    Inoue, Satoru
    Vaidya, Soniya
    Tillmann, Hanns-Christian
    Sakita, Yohei
    Machineni, Surendra
    Heudi, Olivier
    Furihata, Kenichi
    BMC PULMONARY MEDICINE, 2021, 21 (01)
  • [2] Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate administered as an inhaled fixed-dose combination in Japanese and Caucasian healthy subjects
    Satoru Inoue
    Soniya Vaidya
    Hanns-Christian Tillmann
    Yohei Sakita
    Surendra Machineni
    Olivier Heudi
    Kenichi Furihata
    BMC Pulmonary Medicine, 21
  • [3] Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate following once daily inhalation as a fixed-dose combination in healthy subjects
    Tillmann, Hanns-Christian
    Ethel, Brian
    Abdallah, Nasri
    Machineni, Surendra
    Drollmann, Anton
    Last, Stephanie
    Hahn, Michael
    Radhakrishnan, Rajkumar
    Ignatenko, Stanislav
    Vaidya, Soniya
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [4] Pharmacokinetics of indacaterol and mometasone furoate delivered alone or in a free or fixed dose combination in healthy subjects
    Vaidya, Soniya S.
    Khindri, Sanjeev
    Calder, Nicole
    Machineni, Surendra
    Hara, Hisanori
    Majumdar, Tapan
    Febbraro, Salvatore
    Fuhr, Rainard
    Woessner, Ralph
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2016, 37 : 30 - 36
  • [5] Inhaled indacaterol/glycopyrronium/mometasone furoate fixed-dose combination in moderate-to-severe asthma
    Perez de Llano, Luis
    Naval, Elsa
    Mejia, Natalia
    Dominguez-Ortega, Javier
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2022, 16 (01) : 1 - 15
  • [6] Dose bridging data for mometasone furoate in once-daily fixed-dose inhaled combinations of mometasone furoate/indacaterol and mometasone furoate/ indacaterol/glycopyrronium in patients with asthma
    Buhl, Roland
    Nikolaev, Ivan
    Tillmann, Hanns-Christian
    Vaidya, Soniya
    Bartels, Christian
    Jain, Monish
    Jauernig, Juergen
    Kerstjens, Huib A. M.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2021, 70
  • [7] Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate following once-daily inhalation as a combination in healthy subjects
    Vaidya, Soniya
    Jauernig, Juergen
    Ethell, Brian
    Abdallah, Nasri
    Machineni, Surendra
    Drollmann, Anton
    Heudi, Olivier
    Last, Stefanie
    Hahn, Michael
    Radhakrishnan, Rajkumar
    Ignatenko, Stanislav
    Tillmann, Hanns-Christian
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2020, 64
  • [8] Dose bridging data for mometasone furoate in once-daily fixed-dose inhaled combinations of mometasone furoate/indacaterol and mometasone furoate/indacaterol/glycopyrronium in patients with asthma (vol 70, 102068, 2021)
    Buhl, Roland
    Nikolaev, Ivan
    Tillmann, Hanns-Christian
    Vaidya, Soniya
    Bartels, Christian
    Jain, Monish
    Jauernig, Juergen
    Kerstjens, Huib A. M.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2022, 73
  • [9] Indacaterol/glycopyrronium/mometasone fixed dose combination for uncontrolled asthma
    Pelaia, Corrado
    Crimi, Claudia
    Crimi, Nunzio
    Ricciardi, Luisa
    Scichilone, Nicola
    Valenti, Giuseppe
    Bonavita, Ornella
    Andaloro, Stefano
    Morini, Paolo
    Rizzi, Andrea
    Pelaia, Girolamo
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2022, 16 (02) : 183 - 195
  • [10] Corresponding doses of mometasone furoate (MF) in once-daily inhaled fixed-dose combination (FDC) of indacaterol/mometasone furoate (IND/MF) and indacaterol/glycopyrronium/mometasone furoate (IND/GLY/MF): results from randomized clinical studies
    Buhl, Roland
    Kerstjens, Huib
    Nikolaev, Ivan
    Vaidya, Soniya
    Bartels, Christian
    Jain, Monish
    Jauernig, Juergen
    Kottakis, Ioannis
    Qian, Chenyu
    Tillman, Hanns-Christian
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB59 - AB59
12345